Navigation Links
Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea

arter ending March 31, 2007. Genzyme cautions investors not to place substantial reliance on the forward- looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise these statements.

Genzyme(R) is a registered trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-678-999-4572 outside the United States.


    Media Contact:            Investor Contact:

    Maria Cantor              Sally Curley

    (617) 768-6690            (617) 768-6140

CONTACT: Media, Maria Cantor, +1-617-768-6690; Investors, Sally Curley,+1-617-768-6140, both of Genzyme Corp.

Web site: http://www.genzyme.com//

Company News On-Call: http://www.prnewswire.com/comp/113803.html /

Ticker Symbol: (NASDAQ-NMS:GENZ)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Results of Clinical Trial of Hylastan
2. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/20/2008)...ice leads to 100% patient response ... /- BARRX Medical, Inc., a global,tec...day announced the,publication of two related Europ...r early esophageal cancer and pre-cancerous dyspla...n therapy with the HALO ablation,system. Barrett,s...
(Date:5/20/2008)...l/ -- Delcath Systems, Inc.,(Nasdaq: DCTH ) annou...tive,Officer, provided an update on enrollment num...rial today at a gathering of financial and healthc...w 5th Annual Global,Healthcare Conference., Mr. T... for the Phase,III clinical trial of the Company,s...
(Date:5/19/2008)... MORE SCIENCE SUPPORTING THE, THEORY THAT VACCINE...ewswire-USNewswire/ -- A primate model for autism,...s unveiled at the,International Meeting For Autism...scores the critical need for studies into vaccine ...n of autistic children. The National,Autism Associ...
(Date:5/19/2008)...ss Shionogi Phase 3 results on .../- InterMune, Inc.,(Nasdaq:...development of,pirfenidone for the treatment of id...st Track" designation from the U.S. Food and Drug,...that the FDA reserves for,a drug intended to treat...
Breaking Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 2Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 3UPDATE: Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Behavioral Symptoms of Autism 2InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA 2InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA 3Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 1Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 2Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 3Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 4Metabolic syndrome affects nearly 1 in 10 US teens 10120 1Metabolic syndrome affects nearly 1 in 10 US teens 10120 2Metabolic syndrome affects nearly 1 in 10 US teens 10120 3NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 1NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 2NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 3Bill Germanakos and Hollie Self Bring The Biggest Loser Million Pound Tour Presented by MSN to Arizona Mills Mall 10114 1Bill Germanakos and Hollie Self Bring The Biggest Loser Million Pound Tour Presented by MSN to Arizona Mills Mall 10114 2
...ind these data reassuring", PHILADELPHIA, June 05,...id today that findings from an interim analysis,of...mes and,Regulation of glycemia in Diabetes), a pro...etermine cardiovascular outcomes in more,than 4,40...ence to,the overall cardiovascular safety profile ...
...--Jun 5, 2007 - Elixir,Pharmaceuticals, Inc., anno...n antagonism as a potential method for regulating,...ood glucose. The,data were presented in poster ses... Annual Meeting, being held in Toronto,Canada. El...at and,prevent metabolic disease, as well as preve...
Other Medicine Technology:Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 2Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 3Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 4Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 5Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4
(Date:5/20/2008)...e/ -- Ambulatory Services of,America, Inc. announc...h,joint venture to provide outpatient radiation on... between Denton Cancer Center, LP and ASA,s,subsid... ROSA of Denton,will own and operate a radiation t...ly owned and operated by Denton Cancer Center., (...
(Date:5/20/2008)...ng new out-patient procedures at no ... Calif., May 20 /PRNewswire/ -- Compass Clinical R... San Francisco Bay Area (RSC) are,hoping to recrui...nx, a,build-up of fluid in the fallopian tubes tha... as a part of a study of the effectiveness of a ne...
(Date:5/20/2008)...turated Fat - and with Omega-3, PARAMUS, N.J., Ma...(Nasdaq: SMBL ) has launched Smart Balance(R) But...utter Blend Sticks are 50 percent real butter,and ...art Balance(R) Butter,Blend Sticks are offered in ...or a healthier and tasty alternative for use in co...
(Date:5/20/2008)...ery or survival, researchers say. , , T...y dialysis for patients with acute kidney injury d...reduce the rate of organ failure, a new study find...n seen in critically ill patients. Approximately 2...d 35 percent of critically ill patients, will suff...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 3Health News:New Smart Balance(R) Butter Blend Sticks Make Healthier Cooking & Baking Easy 2Health News:More Dialysis Not Better in Acute Kidney Injury 2
...gnal is thought to worsen the symptoms of MS, say ...ach that holds promise in the development of novel...sease, for which a concrete cure is not yet in pla...xercise to effectively impede the protein that is ...
...s of surgery to separate four-year-old conjoined t... intestines and pelvis and are working// to separa...s billed as the first to try to separate twins who...d Maliyah Herrin are joined at mid-torso and also ...
... hundreds of thousands displaced by the Israel-Hez...towards severe shortages of fuel// and drinking wa...faced with a major setback - and with the fuel pro...owards a de-facto blockade of the country," said a...
... and Drug Administration's decision on whether to ...en before the scientists submitted their recommend... sworn statements before court. Dr. John Jenkins,...rugs, said in a sworn statement in June that he wa...
Other Medicine News:Health News:Lebanon Fears of Epidemics as the Crisis Deepens 2
Stainless steel threaded Steinman Pins available in point types A,D, E, and F.
Swanson Finger Pins are stainless steel and available in one length and three diameters.
Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters.
...ng Jet-X Pin products are available: , 5mm x 30mm ...6 Cannulated H-Pin , 5mm x 50mm Traction Pin ...SST Half Pin , TI 5mm Half Pin , TI 5mm x ...in , TI Half Pin , TiN 5 x 40, 1.6 Cann ...
Medicine Products: